Coronavirus

Vaccination

The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program.

All available COVID-19 vaccines continue to provide strong protection against serious disease. The new XBB 1.5 vaccines have been found to provide modest improved protection against the COVID-19 strains circulating in the community. The XBB 1.5 vaccines will be available along with the existing bivalent vaccines.

There is no change to current vaccine eligibility recommendations. The new vaccine is a good reminder for people to get vaccinated if they haven’t had their recommended dose(s) in 2023 – SEE BELOW

Pfizer’s monovalent XBB.1.5 vaccine will be available for use in eligible people aged 5 years and older, while the Moderna monovalent XBB.1.5 vaccine can be used for those aged 12 years and older.

Recommendations  2024

• The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation (ATAGI) on the National COVID-19 Vaccine Program for 2024.
• In 2024, those aged 75 years and over continue to be recommended a dose of COVID-19 vaccine every six months.
• Those aged over 65 years of age, and adults with severe immunocompromise, continue to be eligible to receive a COVID-19 vaccine dose every 6 months.
• All other adults can receive a single dose this year.
• You cannot have the covid vaccine if you have had covid-19 infection the preceding 6 months.